Your Location:Home >Products >Intermediates >877399-73-0

877399-73-0

  • Product Name1-Piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester
  • Molecular FormulaC13H20IN3O2
  • Molecular Weight377.225
  • Purity99%
Inquiry

Product Details

Quick Details

  • CasNo: 877399-73-0
  • Molecular Formula: C13H20IN3O2
  • Purity: 99%

Quality Factory Supply Buy High Grade 1-Piperidinecarboxylic  acid,  4-(4-iodo-1H-pyrazol-1-yl)-,  1,1-dimethylethyl  ester 877399-73-0 with Safe Shipping

  • Molecular Formula:C13H20IN3O2
  • Molecular Weight:377.225
  • Vapor Pressure:0mmHg at 25°C 
  • Melting Point:97 °C 
  • Boiling Point:430.596oC at 760 mmHg 
  • PKA:1.08±0.19(Predicted) 
  • Flash Point:214.217oC 
  • PSA:47.36000 
  • Density:1.603g/cm3 
  • LogP:2.99760 

1-Piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester(Cas 877399-73-0) Usage

General Description

1-Piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, also known as Tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate, is a chemical compound used in organic synthesis and pharmaceutical research. It is commonly employed as a building block in the development of new drugs and agrochemicals. This ester derivative is known for its potential therapeutic activities and is used as a starting material in the production of various pharmaceuticals and biologically active compounds. Its unique chemical structure and properties make it a valuable component in drug discovery and development efforts.

InChI:InChI=1/C13H20IN3O2/c1-13(2,3)19-12(18)16-6-4-11(5-7-16)17-9-10(14)8-15-17/h8-9,11H,4-7H2,1-3H3

877399-73-0 Relevant articles

Pyrrolo[2, 3-d] pyrimidine derivatives containing piperidine as well as preparation and application thereof

-

Paragraph 0121; 0126; 0127, (2020/09/16)

The invention relates to a piperidine-co...

Hydrochloride of [1, 2, 4] triazine and [6,1-a] isoindole compound and application thereof

-

Paragraph 0049-0050; 0059-0063, (2020/03/13)

The invention belongs to the field of ch...

INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS

-

Page/Page column 54-55, (2020/05/15)

The present disclosure is directed to co...

Preparation method of tert-butyl 4-(4-halo-1H-pyrazol-1-yl)piperidin-1-carboxylate

-

Paragraph 0038; 0040, (2020/04/17)

The invention discloses a preparation me...

877399-73-0 Process route

4-iodopyrazole
3469-69-0

4-iodopyrazole

1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate
141699-59-4

1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate

tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate
877399-73-0

tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate

Conditions
Conditions Yield
4-iodopyrazole; With sodium hydride; In dichloromethane; mineral oil; at 0 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In dichloromethane; mineral oil; at 100 ℃; for 15h;
70.2%
4-iodopyrazole; With sodium hydride; In dichloromethane; mineral oil; at 0 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In dichloromethane; mineral oil; at 100 ℃; for 15h;
70.2%
With sodium hydride; In N,N-dimethyl-formamide; at 100 ℃; for 14h; Cooling with ice;
68.7%
With NaH; In N,N-dimethyl-formamide; pentane;
66%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 4 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; at 100 ℃; for 12h;
66%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 4 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In 1,2-dimethoxyethane; at 100 ℃; for 12h;
66%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 4 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; at 100 ℃; for 12h;
66%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 4 ℃; for 1h; Inert atmosphere;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; at 100 ℃; for 12h; Inert atmosphere;
66%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 4 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; mineral oil; at 100 ℃; for 12h;
66%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 4 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; at 4 - 100 ℃; for 12h;
66%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 4 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; at 100 ℃; for 12h;
66%
With potassium carbonate; In N,N-dimethyl-formamide; at 60 ℃;
60.67%
With potassium carbonate; In N,N-dimethyl-formamide; at 60 ℃;
60.67%
With caesium carbonate; In n-methyl-2-pyrrilidone; at 80 ℃; for 18.5h;
57%
With caesium carbonate; at 80 ℃; for 8h; Inert atmosphere;
57.9%
at 80 ℃; for 8h; Inert atmosphere;
57.9%
With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 110 ℃; for 0.5h; Inert atmosphere; Microwave irradiation;
55%
4-iodopyrazole; 1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; With sodium hydride; In N,N-dimethyl-formamide; mineral oil; Inert atmosphere;
In N,N-dimethyl-formamide; mineral oil; at 110 ℃; for 0.5h; Microwave irradiation; Inert atmosphere;
55%
With potassium carbonate; In N,N-dimethyl-formamide; at 100 ℃;
51%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; mineral oil; at 0 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; mineral oil; at 100 ℃; for 16h;
41%
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 0 - 20 ℃; for 2h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; at 100 ℃; for 12h;
620 mg
With sodium hydride; In N,N-dimethyl-formamide;
 
With caesium carbonate; In 1-methyl-pyrrolidin-2-one; at 70 ℃; for 5h; Temperature;
 
4-iodopyrazole; With sodium hydride; In N,N-dimethyl-formamide; at 0 ℃; for 1h;
1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate; In N,N-dimethyl-formamide; at 100 ℃; for 12h; Enzymatic reaction;
 
With caesium carbonate; In 1-methyl-pyrrolidin-2-one; at 80 ℃; for 16h;
900 mg
4-iodopyrazole
3469-69-0

4-iodopyrazole

tert-butyl 4-(tosyloxy)piperidin-1-carboxylate
118811-07-7

tert-butyl 4-(tosyloxy)piperidin-1-carboxylate

tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate
877399-73-0

tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate

Conditions
Conditions Yield
With caesium carbonate; In N,N-dimethyl acetamide; at 100 ℃; for 1h; Inert atmosphere;
92%
With caesium carbonate; In N,N-dimethyl acetamide; at 100 ℃; for 1h; Inert atmosphere;
92%

877399-73-0 Upstream products

  • 3469-69-0
    3469-69-0

    4-iodopyrazole

  • 141699-59-4
    141699-59-4

    1-(tert-butoxycarbonyl)piperidin-4-yl methanesulfonate

  • 109384-19-2
    109384-19-2

    t-butyl 4-hydroxy piperidine-1-carboxylate

  • 189205-49-0
    189205-49-0

    4-methanesulfonylpiperidine-1-carboxylic acid tert-butyl ester

877399-73-0 Downstream products

  • 877399-74-1
    877399-74-1

    tert-butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate

  • 1190875-39-8
    1190875-39-8

    (1-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}-1H-pyrazol-4-yl)boronic acid

  • 1613332-92-5
    1613332-92-5

    3-((2,5-difluorophenyl)ethynyl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine

;